The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...

The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to fight respiratory viruses like COVID-19 and the flu.

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...

Kennedy urged HHS to move away from mRNA vaccines and "invest in better solutions," but did not specify alternatives.

President Trump’s announcement of new tariffs on semiconductors and pharmaceuticals kept markets in flux. Plus: Drugmaker Pfizer boosted its annual profit guidance. And, data-software company Palantir ...

Pfizer CEO Albert Bourla announced that major pharmaceutical companies are ready to work with the Trump administration to ...

The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, ...

Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...

Pfizer is starting to execute on its turnaround plan and drug pipeline. 10 stocks we like better than Pfizer › Shares of the ...